Patent ID: 8575194
Filing Date: 2013-11-05
Classification: A61K

Abstract:
1. A method, comprising administering to a patient suffering from cognitive short term memory loss, a therapeutically effective amount of a composition comprising a member of the family -lukast, wherein the composition reverses said cognitive short term memory loss for a specified period of time for relief, said method further comprising: administering orally a 10 mg first dose of montelukast sodium upon awakening; administering a 10 mg second dose of montelukast sodium about two hours after said first dose; administering a 5 mg third dose of montelukast sodium about three to four hours after said second dose; administering a 5 mg fourth dose of montelukast sodium about three to four hours after said third dose; optionally administering a 10 mg fifth dose of montelukast sodium about three to four hours after said fourth dose.